Specially - marked Centers of Excellence feature comprehensive care teams that meet every patient need and
provide access to clinical trials and experimental therapies.
As one of the National Cancer Institute's designated cancer centers, Rutgers Cancer Institute of New Jersey is able to
provide access to clinical trials not available at other hospitals, clinics or doctor's offices, as well as access to some of the most advanced, targeted treatments and medicines available.
Not exact matches
The GP practices were involved in ensuring the study not only had
access to specific COPD patients but also that the usual
clinical care
provided by the practices was built into the
trials — the study was therefore rooted in a real
clinical environment unlike tradition efficacy
trial model.
As one of this nation's 49 National Cancer Institute (NCI)- designated Comprehensive Cancer Centers, Rutgers Cancer Institute is able
to offer its patients
access to clinical trials available only at NCI - designated centers
providing the most advanced treatments available.
We
provide access to the latest medicines and technology, as well as the most advanced
clinical trials including novel personalized targeted therapies including precision medicine and immunotherapy - some that are only offered at NCI - designated Comprehensive Cancer Centers like ours.
iBET's infrastructure comprises 16 laboratories fully equipped with state - of - the - art technology (70 m2 each), including a BSL2 laboratory for working with viruses; a GMP Analytical Services Unit certified by the INFARMED (the Portuguese medicines authority, EMA Portuguese branch) and by DGAV (the Portuguese veterinary authority) for quality control and batch release of human and veterinary pharmaceuticals, biopharmaceuticals as well as experimental new drugs; a GMP Mass - Spectroscopy Unit that
provides state - of - the - art MS services
to the scientific community and Industry; a 2600 m2 bio-pilot plant supporting production and purification of proteins ATMPs and vaccines from bench top
to 300 L scale and privileged
access to GeniBET Biopharmaceuticals, an iBET spin - off producing ATMPs under cGMP certification for phase I / II / III
clinical trials.
We are leaders in cancer medicine
providing patients with
access to clinical trials and new, breakthrough therapies.
Cutting edge
clinical research conducted within the Program
provides patients with
access to the latest
clinical trials and novel therapeutics.
Penn's multidisciplinary approach
to the diagnosis and treatment of mesothelioma
provides better outcomes and gives you
access to the most advanced treatment, surgical techniques and
clinical trials.
In fact, C.S. Mott Children's Hospital is one of only a few pediatric centers in the country
providing patients
access to Phase 1
clinical trials.
Our patients have
access to many innovative Phase 1
Clinical Trials,
providing hope for many refractory or relapsing patients for whom standard treatment options have failed.
Along with our collaborator in this program, Ludwig Cancer Research, we work
to identify promising new drug combinations, partner with companies
to gain
access to these drugs, and then
provide investment capital and
clinical trial support
to the academic investigators
to help kick - start
clinical development.
C.S. Mott Children's Hospital is one of only a few pediatric centers in the country
providing patients
access to Phase 1
clinical trials.
Overall, SR - Tiget represents a multi-disciplinary research environment, which
provides a unique blend of scientific expertise in the development of innovative gene and cell therapy strategies,
access to relevant preclinical models
to evaluate their efficacy and safety, as well as competence in conducting early phase
clinical trials.
Platelet Function Disorders Program The Platelet Function Disorders Program
provides comprehensive care for children and adolescents with platelet function disorders, as well as
access to the most recent
clinical trials.
Rutgers Cancer Institute
provides multidisciplinary, state - of - the - art cancer care including
access to the latest medicines and most advanced treatment options available such as
clinical trials.
Our multidisciplinary team works together each and every day
to provide personalized treatment plans
to our patients, as well as
access to the latest therapies and
clinical trials.
Phase 1
clinical trials are used in patients for whom conventional treatment has not worked,
providing access to pivotal first - in - children, early - stage
clinical trials with novel treatments before they are widely available.